Carmen Peña1, Gabriel Cabot2, Silvia Gómez-Zorrilla1, Laura Zamorano2, Alain Ocampo-Sosa3, Javier Murillas2, Benito Almirante4, Virginia Pomar5, Manuela Aguilar6, Ana Granados7, Esther Calbo8, Jesús Rodríguez-Baño9, Fernando Rodríguez-López10, Fe Tubau1, Luis Martínez-Martínez11, Antonio Oliver2. 1. Servicio de Enfermedades Infecciosas, Hospital Universitario de Bellvitge-IDIBELL, Barcelona. 2. Unidad de Investigación, Servicio de Microbiología y Servicio de Medicina Interna, Hospital Universitario de Son Espases, Instituto de Investigación Sanitaria de Palma, Palma de Mallorca. 3. Servicio de Microbiología, Hospital Universitario Marqués de Valdecilla-IFIMAV, Santander. 4. Servicio de Enfermedades Infecciosas, Hospital Universitario Vall d'Hebrón. 5. Unidad de Enfermedades Infecciosas, Hospital Santa Creu i Sant Pau, Barcelona. 6. Servicio de Enfermedades Infecciosas, Hospital Universitario Virgen del Rocío, Sevilla. 7. Sección de Enfermedades Infecciosas, Consorci Hospitalari Parc Taulí, Sabadell. 8. Sección de Enfermedades Infecciosas, Hospital Mutua de Terrasa. 9. Sección de Enfermedades Infecciosas, Hospital Universitario Virgen Macarena, Sevilla. 10. Servicio de Microbiología Infecciosas, Hospital Universitario Reina Sofía-IMIBIC, Córdoba. 11. Servicio de Microbiología, Hospital Universitario Marqués de Valdecilla-IFIMAV, Santander Departamento de Biología Molecular, Universidad de Cantabria, Santander, Spain.
Abstract
BACKGROUND: The type III secretion system (TTSS) is a major virulence determinant of Pseudomonas aeruginosa. The objective of this study was to determine whether the TTSS genotype is a useful prognostic marker of P. aeruginosa bacteremia mortality. We also studied the potential association between TTSS genotypes and multidrug-resistant (MDR) profiles, and how this interaction impacts the outcome of bloodstream infections. METHODS: We performed a post hoc analysis of a published prospective multicenter cohort of P. aeruginosa bloodstream infections. The impact in mortality of TTSS genotypes (exoS, exoT, exoU, and exoY genes) and resistance profiles was investigated. Cox regression analysis was used to control for confounding variables. RESULTS: Among 590 patients, the 30-day mortality rate was 30% (175 patients), and 53% of them died in the first 5 days (early mortality). The unadjusted probabilities of survival until 5 days was 31.4% (95% confidence interval [CI], 17.4%-49.4%) for the patients with exoU-positive isolates and 53.2% (95% CI, 44.6%-61.5%) for exoU-negative isolates (log rank P = .005). After adjustment for confounders, exoU genotype (adjusted hazard ratio [aHR], 1.90 [95% CI, 1.15-3.14]; P = .01) showed association with early mortality. In contrast, late (30-day) mortality was not influenced by TTSS genotype but was independently associated with MDR profiles (aHR,1.40 [95% CI, 1.01-1.94]; P = .04). Moreover, the exoU genotype (21% of all isolates) was significantly less frequent (13%) among MDR strains (particularly among extensively drug-resistant isolates, 5%), but was positively linked to moderately resistant (1-2 antipseudomonals) phenotypes (34%). CONCLUSIONS: Our results indicate that the exoU genotype, which is associated with specific susceptibility profiles, is a relevant independent marker of early mortality in P. aeruginosa bacteremia.
BACKGROUND: The type III secretion system (TTSS) is a major virulence determinant of Pseudomonas aeruginosa. The objective of this study was to determine whether the TTSS genotype is a useful prognostic marker of P. aeruginosa bacteremia mortality. We also studied the potential association between TTSS genotypes and multidrug-resistant (MDR) profiles, and how this interaction impacts the outcome of bloodstream infections. METHODS: We performed a post hoc analysis of a published prospective multicenter cohort of P. aeruginosa bloodstream infections. The impact in mortality of TTSS genotypes (exoS, exoT, exoU, and exoY genes) and resistance profiles was investigated. Cox regression analysis was used to control for confounding variables. RESULTS: Among 590 patients, the 30-day mortality rate was 30% (175 patients), and 53% of them died in the first 5 days (early mortality). The unadjusted probabilities of survival until 5 days was 31.4% (95% confidence interval [CI], 17.4%-49.4%) for the patients with exoU-positive isolates and 53.2% (95% CI, 44.6%-61.5%) for exoU-negative isolates (log rank P = .005). After adjustment for confounders, exoU genotype (adjusted hazard ratio [aHR], 1.90 [95% CI, 1.15-3.14]; P = .01) showed association with early mortality. In contrast, late (30-day) mortality was not influenced by TTSS genotype but was independently associated with MDR profiles (aHR,1.40 [95% CI, 1.01-1.94]; P = .04). Moreover, the exoU genotype (21% of all isolates) was significantly less frequent (13%) among MDR strains (particularly among extensively drug-resistant isolates, 5%), but was positively linked to moderately resistant (1-2 antipseudomonals) phenotypes (34%). CONCLUSIONS: Our results indicate that the exoU genotype, which is associated with specific susceptibility profiles, is a relevant independent marker of early mortality in P. aeruginosa bacteremia.
Authors: Richard A Murphy; Luba Nisenbaum; Amy S Labar; Robert L Sheridan; Jean-Baptiste Ronat; Kelly Dilworth; Jade Pena; Erin Kilborn; Carrie Teicher Journal: World J Surg Date: 2016-07 Impact factor: 3.352
Authors: Gabriel Cabot; Carla López-Causapé; Alain A Ocampo-Sosa; Lea M Sommer; María Ángeles Domínguez; Laura Zamorano; Carlos Juan; Fe Tubau; Cristina Rodríguez; Bartolomé Moyà; Carmen Peña; Luis Martínez-Martínez; Patrick Plesiat; Antonio Oliver Journal: Antimicrob Agents Chemother Date: 2016-11-21 Impact factor: 5.191
Authors: Ester Del Barrio-Tofiño; Carla López-Causapé; Gabriel Cabot; Alba Rivera; Natividad Benito; Concepción Segura; María Milagro Montero; Luisa Sorlí; Fe Tubau; Silvia Gómez-Zorrilla; Nuria Tormo; Raquel Durá-Navarro; Esther Viedma; Elena Resino-Foz; Marta Fernández-Martínez; Claudia González-Rico; Izaskun Alejo-Cancho; Jose Antonio Martínez; Cristina Labayru-Echverria; Carlos Dueñas; Ignacio Ayestarán; Laura Zamorano; Luis Martinez-Martinez; Juan Pablo Horcajada; Antonio Oliver Journal: Antimicrob Agents Chemother Date: 2017-10-24 Impact factor: 5.191
Authors: Irina Sánchez-Diener; Laura Zamorano; Carla López-Causapé; Gabriel Cabot; Xavier Mulet; Carmen Peña; Rosa Del Campo; Rafael Cantón; Antonio Doménech-Sánchez; Luis Martínez-Martínez; Susana C Arcos; Alfonso Navas; Antonio Oliver Journal: Antimicrob Agents Chemother Date: 2017-11-22 Impact factor: 5.191
Authors: Silvia Gómez-Zorrilla; Francisco Morandeira; María José Castro; Fe Tubau; Elisabet Periche; Rosario Cañizares; María Angeles Dominguez; Javier Ariza; Carmen Peña Journal: Microb Drug Resist Date: 2016-10-18 Impact factor: 3.431